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1Pamukkale University Medical Faculty, Department of Chest, Pamukkale,
2Pamukkale University Medical Faculty, Department of Cardiology, Pamukkale
Objectives: Right ventricular (RV) dysfunction with myocardial damage may lead to
fatal complications in patients with acute pulmonary embolism (PE). Cytoplasmic
heart-type fatty acid binding protein (H-FABP) and N-terminal fragment of its pro-
hormone (NTproBNP) are sensitive and speciﬁc biomarkers of myocardial damage.
We evaluated RV dysfunction and cardiac biomarkers for myocardial damage and
short-term risk stratiﬁcation in patients with acute PE.
Methods: We analyzed 41 patients (24 female, 17 male) with conﬁrmed acute PE.
Three groups (massive, submassive and non-massive) of patients were deﬁned, based
on systemic systolic blood pressure measured on admission and the RV dysfunction
by transthoracic echocardiography (TTE). Also, systolic (s) and mean (m) pulmonary
artery pressures (PAP) were recorded by TTE, and plasma concentrations of cardiac
troponin T (cTnT), myoglobin (Mb), NT-proBNP, and H-FABP were analyzed.
Results: Twelve (29,3%) patients died (3 PE related deaths) and 17 (41,5%) expe-
rienced complicated clinical course- in 6 month follow-up- the combined end-point
including at least one of the following: death, chronic PE, pulmonary hypertension
and recurrent PE. Hazard ratio analysis demonstrated that PAPs, PAPm, plasma H-
FABP, NT-proBNP, cTnT and Mb concentrations predicted fatal outcome. When only
PE-related deaths were considered, PAPs, plasma H-FABP and NT-proBNP
concentrations indicated fatal outcome. Multivariate hazard ratio analysis revealed H-
FABP, NT-proBNP and PAPs as the only 6-month mortality predictor. (HR 1.02 CI
95% 1.01–1.05, 1.01 CI 95% 1.01–1.04 and 1.02 CI 95% 1.02–1.05 respectively).
Conclusions: H-FABP, NT-proBNP and PAPs measured on admission are useful for
short-term risk stratiﬁcation and in the prediction of 6-month PE-related mortality in
patients with acute PE.
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Background: Despite advanced therapeutic options, acute pulmonary embolism (PE)
is still related to high mortality and morbidity rates. Determination of the high risk
patients requiring more aggressive therapy and close monitoring remains an important
issue. Acute pulmonary embolism increases the pressures of the right heart chambers
and may cause various reﬂections that can be detected on surface electrocardiography
(ECG). We aimed to demonstrate relations of QT and P wave dispersions with early
death in the course of acute pulmonary embolism.
Methods: The archive data of 54 patients who had been hospitalized in our hospital with
the diagnosis of PE (whom had ﬁnal diagnosis after the exact demonstration of thrombus
in pulmonary arteries via computed tomography) between January 2012 and April 2013
was retrospectively reviewed. 33 patients whowere in sinus rhythm andwhose datawere
suitable for QT interval and P wave analyses were included to the study. ECG's obtained
within the ﬁrst 12 hours of hospital admission were included in the study. Patients with
atrial ﬁbrillation during admission or excessive noises in ECG were excluded from the
study. Retrospective analyses of corrected QT interval dispersions and P wave disper-
sions were performed for each patients. Three consecutive beats were used for the
analyses where at least 10 leads were analyzable in ECGs.
Results: Among the study population, 7 patients (%21,2) died and 26 patients
(%78,8) lived after the diagnosis of PE. P wave dispersion values of deaths were
signiﬁcantly higher than those who survived (73 (69,5-82,5) versus 51 (39,6-57,6)
respectively, p¼0,000). Moreover, QTcd values of deaths were also signiﬁcantly
higher than the survivors (119 (103-120) versus 76 (66,5-88,5) respectively,
p¼0,000). There was not any signiﬁcant difference between the survivors and deaths
by means of age, gender, smoking habit, D-dimer levels and accompanying diseases
like diabetes, hypertension, malignity, chronic obstructive pulmonary disease (COPD)
and deep venous thrombosis (p>0,05). Troponin I serum levels were signiﬁcantly
higher in deaths (15,913,8 versus 2,110,2, p¼0,01) and hemoglobin levels were
signiﬁcantly lower (10,6 (9-11,3) versus 12 (11-13,3), p¼0,034).
Conclusions: To the best of our knowledge this study, for the ﬁrst time demonstrated
close relation of Pd with early death in the course of acute PE. In order, to detect those
who were under potential high risk and who need more aggressive treatment, ECG
parameters like Pd and QTcd may be used as useful markers.
Table 1. Demographic characteristics and laboratory ﬁndings of patients with
and without ED
Variables
Patients
without ED
(n¼90)
Patients
with ED
(n¼110) P
Age (years) 53.29.4 58.58.2 <0.001
Diabetes Mellitus n (%) 8(8.8) 21 (19.1) 0.05
Smoking n (%) 25(27.8) 42(38.2) 0.06
Body Mass Index 29.03.3 29.44.3 0.45
Systolic Blood Pressure (mm/Hg) 145.517.4 145.722.2 0.94
Diastolic Blood Pressure (mm/Hg) 89.812.5 87.712.4 0.46
Fasting Blood Glucose (mg/dL) 99.320.4 112.437.8 0.003
Urea (mg/dL) 28.111.7 26.712.7 0.46
Creatinine (mg/dL) 0.90.1 1.00.2 0.001
Sodium (mmol/L) 139.62.6 138.214.0 0.41
Potassium (mmol/L) 4.30.4 4.73.5 0.33
Uric acid (mg/dL) 5.441.32 6.201.6 0.01
Glomerular Filtration Rate (ml/
minutes)
117.321.3 103.125.7 <0.001
Diuretics 38 (42.2) 34 (31.0) 0.74
Beta Blockers n (%) 16 (17.8) 34 (30.9) 0.04
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